These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8778018)

  • 1. Engineering of recombinant soluble CD46: an inhibitor of complement activation.
    Christiansen D; Milland J; Thorley BR; McKenzie IF; Mottram PL; Purcell LJ; Loveland BE
    Immunology; 1996 Mar; 87(3):348-54. PubMed ID: 8778018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hyperacute transplant rejection by soluble proteins with the functional domains of CD46 and FcgammaRII.
    Lanteri MB; Powell MS; Christiansen D; Li YQ; Hogarth M; Sandrin MS; Mckenzie IF; Loveland BE
    Transplantation; 2000 Mar; 69(6):1128-36. PubMed ID: 10762218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro.
    Christiansen D; Milland J; Thorley BR; McKenzie IF; Loveland BE
    Eur J Immunol; 1996 Mar; 26(3):578-85. PubMed ID: 8605924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
    Iwata K; Seya T; Yanagi Y; Pesando JM; Johnson PM; Okabe M; Ueda S; Ariga H; Nagasawa S
    J Biol Chem; 1995 Jun; 270(25):15148-52. PubMed ID: 7541036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis.
    Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
    Transpl Immunol; 1993; 1(2):101-8. PubMed ID: 8081768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation.
    Devaux P; Christiansen D; Fontaine M; Gerlier D
    Eur J Immunol; 1999 Mar; 29(3):815-22. PubMed ID: 10092084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera.
    Seya T; Hara T; Iwata K; Kuriyama S; Hasegawa T; Nagase Y; Miyagawa S; Matsumoto M; Hatanaka M; Atkinson JP
    Int Immunol; 1995 May; 7(5):727-36. PubMed ID: 7547700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
    Barilla-LaBarca ML; Liszewski MK; Lambris JD; Hourcade D; Atkinson JP
    J Immunol; 2002 Jun; 168(12):6298-304. PubMed ID: 12055245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligation of human CD46 with purified complement C3b or F(ab')(2) of monoclonal antibodies enhances isoform-specific interferon gamma-dependent nitric oxide production in macrophages.
    Hirano A; Kurita-Taniguchi M; Katayama Y; Matsumoto M; Wong TC; Seya T
    J Biochem; 2002 Jul; 132(1):83-91. PubMed ID: 12097164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism.
    Oglesby TJ; Allen CJ; Liszewski MK; White DJ; Atkinson JP
    J Exp Med; 1992 Jun; 175(6):1547-51. PubMed ID: 1588280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.
    Makrides SC; Scesney SM; Ford PJ; Evans KS; Carson GR; Marsh HC
    J Biol Chem; 1992 Dec; 267(34):24754-61. PubMed ID: 1447213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.
    White DJ; Oglesby T; Liszewski MK; Tedja I; Hourcade D; Wang MW; Wright L; Wallwork J; Atkinson JP
    Transpl Int; 1992; 5 Suppl 1():S648-50. PubMed ID: 14621899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection.
    Thorley BR; Milland J; Christiansen D; Lanteri MB; McInnes B; Moeller I; Rivailler P; Horvat B; Rabourdin-Combe C; Gerlier D; McKenzie IF; Loveland BE
    Eur J Immunol; 1997 Mar; 27(3):726-34. PubMed ID: 9079815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional analysis of glycosyl-phosphatidyl inositol-linked CD46 in transgenic mice.
    Shinkel TA; Cowan PJ; Barlow H; Aminian A; Romanella M; Lublin DM; Pearse MJ; d'Apice AJ
    Transplantation; 1998 Dec; 66(11):1401-6. PubMed ID: 9869079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
    Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation.
    Christiansen D; Loveland B; Kyriakou P; Lanteri M; Rubinstein E; Gerlier D
    Mol Immunol; 2000; 37(12-13):687-96. PubMed ID: 11275254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).
    Giannakis E; Jokiranta TS; Ormsby RJ; Duthy TG; Male DA; Christiansen D; Fischetti VA; Bagley C; Loveland BE; Gordon DL
    J Immunol; 2002 May; 168(9):4585-92. PubMed ID: 11971006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD46 (MCP) confers protection from lysis by xenogeneic antibodies.
    Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):396-7. PubMed ID: 8438351
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46).
    Liszewski MK; Leung M; Cui W; Subramanian VB; Parkinson J; Barlow PN; Manchester M; Atkinson JP
    J Biol Chem; 2000 Dec; 275(48):37692-701. PubMed ID: 10960475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.